Capital World Investors Portfolio holdings
Capital World Investors (CWI), a division of Capital Group, one of the oldest and largest investment management firms in the world, was established in 1931 and is headquartered in Los Angeles, California. Specializing in active investment management, CWI focuses on long-term growth through a research-intensive approach, managing hundreds of billions in assets primarily through equity-focused mutual funds and institutional portfolios. It serves a diverse client base, including individual investors, financial advisors, and institutions, and is known for its flagship funds like the American Funds, which emphasize fundamental analysis and a multiple-portfolio-manager system to mitigate risk. With a global reach and a reputation for disciplined, value-oriented investing, CWI remains a cornerstone of Capital Group’s mission to deliver consistent, superior returns.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$5.36B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$5B |
| 3 |
Amazon
AMZN
|
+$3.67B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$3.6B |
| 5 |
TotalEnergies
TTE
|
+$3.2B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$6.34B |
| 2 |
Synopsys
SNPS
|
+$3.12B |
| 3 |
Cloudflare
NET
|
+$2.5B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$2.36B |
| 5 |
Broadcom
AVGO
|
+$2.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.63% |
| 2 | Healthcare | 13.18% |
| 3 | Consumer Discretionary | 12.18% |
| 4 | Financials | 10.99% |
| 5 | Communication Services | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Intuitive Surgical
ISRG
$134B
| $3.71B | 0.51% |
8,048,010
+191,992
| +2% | +$97.1M |
|
52
Aon
AON
$76B
| $3.7B | 0.51% |
11,477,788
-775,116
| -6% | -$258M |
|
53
Alnylam Pharmaceuticals
ALNY
$29.3B
| $3.57B | 0.49% |
10,802,348
-5,499,424
| -34% | -$1.87B |
|
54
Intel
INTC
$513B
| $3.52B | 0.48% |
79,877,133
-24,183,135
| -23% | -$1.11B |
|
55
AbbVie
ABBV
$435B
| $3.45B | 0.47% |
15,841,367
+2,769,923
| +21% | +$614M |
|
56
Brookfield
BN
$108B
| $3.33B | 0.45% |
82,340,675
-16,728,341
| -17% | -$741M |
|
57
Capital One
COF
$134B
| $3.3B | 0.45% |
18,120,639
-6,614,887
| -27% | -$1.38B |
|
|
58
Thermo Fisher Scientific
TMO
$220B
| $3.27B | 0.45% |
6,646,316
-4,357,498
| -40% | -$2.36B |
|
59
Booking.com
BKNG
$161B
| $3.24B | 0.44% |
19,229,025
+3,185,950
| +20% | +$586M |
|
60
Western Digital
WDC
$150B
| $3.21B | 0.44% |
11,880,038
+10,816,431
| +1,017% | +$2.82B |
|
61
Restaurant Brands International
QSR
$25.8B
| $3.17B | 0.43% |
42,858,035
-667,535
| -2% | -$46.9M |
|
62
AT&T
T
$163B
| $3.17B | 0.43% |
109,243,734
+64,066,995
| +142% | +$1.71B |
|
63
Salesforce
CRM
$158B
| $3.12B | 0.43% |
16,711,525
-2,961,159
| -15% | -$614M |
|
|
MRSH
64
Marsh
MRSH
$91.5B
| $3.12B | 0.43% |
17,969,182
+1,044,051
| +6% | +$188M |
|
65
Corteva
CTVA
$51.3B
| $3.01B | 0.41% |
35,998,047
+14,642,858
| +69% | +$1.1B |
|
66
Arthur J. Gallagher & Co
AJG
$63.6B
| $2.99B | 0.41% |
13,817,720
+1,204,349
| +10% | +$278M |
|
67
Baker Hughes
BKR
$61.1B
| $2.96B | 0.4% |
48,433,252
+1,198,298
| +3% | +$69.3M |
|
68
Darden Restaurants
DRI
$24.4B
| $2.93B | 0.4% |
14,928,684
-232,593
| -2% | -$47.8M |
|
69
Johnson & Johnson
JNJ
$625B
| $2.87B | 0.39% |
11,749,361
+2,056,477
| +21% | +$479M |
|
70
FTAI Aviation
FTAI
$22.2B
| $2.85B | 0.39% |
11,646,761
+2,729,931
| +31% | +$723M |
|
|
BA.PRA
71
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$8.27B
| $2.84B | 0.39% |
43,705,702
+10,796,698
| +33% | +$786M |
|
72
Progressive
PGR
$125B
| $2.81B | 0.38% |
14,173,539
+4,650,923
| +49% | +$960M |
|
73
Royal Gold
RGLD
$19.5B
| $2.68B | 0.37% |
10,516,187
+782,380
| +8% | +$208M |
|
74
Nike
NKE
$61.9B
| $2.67B | 0.36% |
50,477,362
+1,407,411
| +3% | +$85.3M |
|
75
Keurig Dr Pepper
KDP
$40.8B
| $2.61B | 0.36% |
99,030,129
+576,257
| +0.6% | +$16.2M |
|
Similar funds
Capital World Investors's Q1 2026 Portfolio in Review
As of Q1 2026, Capital World Investors held 676 positions worth $733B, down 0.32% from $735B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Capital World Investors deployed $25.6B of net new capital in Q1 2026, opening 108 new positions and adding to 262 existing holdings. Its largest new stake was Akamai: 6,764,438 shares worth $777M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Micron Technology, an estimated $6.34B trimmed.
- Capital World Investors's largest Q1 2026 buy was Akamai: 6,764,438 shares worth $777M.
- Capital World Investors added most to AstraZeneca in Q1 2026, an estimated $5.36B increase.
- Capital World Investors's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $6.34B.
- Capital World Investors fully exited Synopsys in Q1 2026, selling an estimated $3.12B.
- Capital World Investors's ten largest holdings make up 28% of its $733B portfolio in Q1 2026.
- Capital World Investors opened 108 new positions and closed 56 in Q1 2026.
- Capital World Investors's portfolio value fell 0.32% quarter-over-quarter to $733B.
Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.